Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]
It's not just Google's Gemini 3, Nano Banana Pro, and Anthropic's Claude Opus 4.5 we have to be thankful for this year around the Thanksgiving holiday here in the U.S.No, today the Germ [...]
London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]
One malicious prompt gets blocked, while ten prompts get through. That gap defines the difference between passing benchmarks and withstanding real-world attacks — and it's a gap most enterprise [...]
The next big trend in AI providers appears to be "studio" environments on the web that allow users to spin up agents and AI applications within minutes. Case in point, today the well-funded [...]
Noom will start offering microdoses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health company continues to adapt to the growing demand for affordable weight-loss solu [...]